Endocrinopathies and renal outcomes in lithium therapy: impact of lithium toxicity

ConclusionStage 3 CKD is common in patients receiving lithium therapy. Lithium toxicity is associated with CKD and hypernatraemia. Thyroid dysfunction and hypercalcaemia are common in patients receiving lithium therapy. Patients receiving lithium therapy require surveillance of renal, thyroid and bone biochemistry.
Source: QJM - Category: Internal Medicine Source Type: research